Importantly, a recent study has revealed that activated ERK 1/2 signaling leads to increased expression of OGT and O-GlcNAcylation levels in various cancers [29], indicating that there is possibly positive feedback between the ERK 1/2 signaling pathway and the O-GlcNAcylation level in cancer cells. Here, OGT is linked to cancer.